Hosted on MSN

ICON expands US early phase research capabilities with new clinic and outpatient centres

ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced the expansion of its early phase capabilities with the opening of a new, state-of-the-art Clinical Research ...
Business Wire

ICON’s Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research ...
FierceBiotech

Icon opens early-phase research unit in San Antonio, plus satellite clinics to grow trial capabilities

Global contract research organization Icon has announced the opening of a new research facility in San Antonio, Texas, along with satellite clinics in Houston and Lawrence, Kansas, to expand its ...
FierceBiotech

ICON Acquires PMG Research, Inc.

ICON plc, (ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the acquisition of PMG Research, Inc., ...
Morningstar

ICON expands US early phase research capabilities with new clinic and outpatient centres

New, 69.5K square-foot, state-of-the-art clinic in Texas integrates clinical, laboratory, and pharmacy infrastructure all under one roof Two new satellite outpatient clinics in Texas and Kansas will ...